Page last updated: 2024-11-02

4-phenylbutyric acid and Bone Loss, Osteoclastic

4-phenylbutyric acid has been researched along with Bone Loss, Osteoclastic in 2 studies

4-phenylbutyric acid: RN refers to the parent cpd
4-phenylbutyric acid : A monocarboxylic acid the structure of which is that of butyric acid substituted with a phenyl group at C-4. It is a histone deacetylase inhibitor that displays anticancer activity. It inhibits cell proliferation, invasion and migration and induces apoptosis in glioma cells. It also inhibits protein isoprenylation, depletes plasma glutamine, increases production of foetal haemoglobin through transcriptional activation of the gamma-globin gene and affects hPPARgamma activation.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Park, HJ1
Son, HJ1
Sul, OJ1
Suh, JH1
Choi, HS1
Li, H1
Li, D1
Ma, Z1
Qian, Z1
Kang, X1
Jin, X1
Li, F1
Wang, X1
Chen, Q1
Sun, H1
Wu, S1

Other Studies

2 other studies available for 4-phenylbutyric acid and Bone Loss, Osteoclastic

ArticleYear
4-Phenylbutyric acid protects against lipopolysaccharide-induced bone loss by modulating autophagy in osteoclasts.
    Biochemical pharmacology, 2018, Volume: 151

    Topics: Animals; Autophagy; Bone Density; Bone Resorption; Cancellous Bone; Cell Survival; Dose-Response Rel

2018
Defective autophagy in osteoblasts induces endoplasmic reticulum stress and causes remarkable bone loss.
    Autophagy, 2018, Volume: 14, Issue:10

    Topics: Animals; Apoptosis; Autophagy; Autophagy-Related Protein 7; Biomarkers; Bone and Bones; Bone Resorpt

2018